{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:45:44Z","timestamp":1777891544439,"version":"3.51.4"},"reference-count":27,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NRE"],"published-print":{"date-parts":[[2021,11,6]]},"abstract":"<jats:p>BACKGROUND: This is the first large study of onabotulinumtoxinA as treatment for pediatric upper limb spasticity. OBJECTIVE: Evaluate efficacy and safety of a single treatment with onabotulinumtoxinA plus occupational therapy (OT). METHODS: In this registrational phase III, multinational study (NCT01603602), participants were randomized 1:1:1 to onabotulinumtoxinA 3\u200aU\/kg\/OT, 6\u200aU\/kg\/OT, or placebo\/OT. Primary endpoint was average change from baseline at weeks 4 and 6 in Modified Ashworth Scale-Bohannon (MAS) score. Secondary endpoints included Modified Tardieu Scale (MTS), Clinical Global Impression of Change (CGI) and functional Goal Attainment Scale (GAS). RESULTS: 235 participants were randomized. At weeks 4 and 6, onabotulinumtoxinA groups had greater mean reductions in MAS (both \u20131.9; p\u200a&lt;\u200a0.001) versus placebo (\u20131.2). OnabotulinumtoxinA doses improved dynamic tone per MTS. Mean CGI at weeks 4 and 6 was unchanged in the overall population, but improved in a post hoc analysis of patients with a single affected upper limb (UL) muscle group (elbow or wrist). GAS score for passive goals was significantly higher for 6\u200aU\/kg versus placebo at week 12. Most AEs were mild\/moderate in severity; overall incidence was similar between groups. CONCLUSIONS: OnabotulinumtoxinA (3 and 6\u200aU\/kg) was safe and effective in reducing upper limb spasticity in pediatric participants.<\/jats:p>","DOI":"10.3233\/nre-210071","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T11:03:09Z","timestamp":1627642989000},"page":"469-479","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of onabotulinumtoxinA with standardized occupational therapy for treatment of pediatric upper limb spasticity: Phase III placebo-controlled randomized trial"],"prefix":"10.1177","volume":"49","author":[{"given":"Rozalina","family":"Dimitrova","sequence":"first","affiliation":[{"name":"Allergan, an AbbVie company, Irvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"McCusker","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie company, Irvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Gormley","sequence":"additional","affiliation":[{"name":"Gillette Children\u2019s Specialty Healthcare, St Paul, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy","family":"Fehlings","sequence":"additional","affiliation":[{"name":"Holland Bloorview Kids Rehab Hospital, Department of Paediatrics, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine E.","family":"Alter","sequence":"additional","affiliation":[{"name":"Mount Washington Pediatric Hospital, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Greaves","sequence":"additional","affiliation":[{"name":"The Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie company, Madison, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell F.","family":"Brin","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie company, Irvine, CA, USA"},{"name":"University of California, Irvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/NRE-210071_ref3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1542\/peds.2007-0854","article-title":"Parent-reported quality of life of children with cerebral palsy in Europe","volume":"121","author":"Arnaud,","year":"2008","journal-title":"Pediatrics"},{"issue":"10","key":"10.3233\/NRE-210071_ref5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1469-8749.2007.00751.x","article-title":"The natural history of gross motor development in children with cerebral palsy aged to years","volume":"49","author":"Beckung,","year":"2007","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"2","key":"10.3233\/NRE-210071_ref6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon,","year":"1987","journal-title":"Physical Therapy"},{"issue":"Suppl 5","key":"10.3233\/NRE-210071_ref7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1468-1331.2001.00048.x","article-title":"Management of upper limb dysfunction in children with cerebral palsy: a systematic review","volume":"8","author":"Boyd,","year":"2001","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.3233\/NRE-210071_ref8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear,","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.3233\/NRE-210071_ref9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.apmr.2003.10.015","article-title":"Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke","volume":"85","author":"Childers,","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.3233\/NRE-210071_ref10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1469-8749.1994.tb11864.x","article-title":"Botulinum toxin in the management of the lower limb in cerebral palsy","volume":"36","author":"Cosgrove,","year":"1994","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"4","key":"10.3233\/NRE-210071_ref11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/WNL.0b013e3181cbcd2f","article-title":"Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","volume":"74","author":"Delgado,","year":"2010","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.3233\/NRE-210071_ref12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2010.03127.x","article-title":"Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement","volume":"17","author":"Fehlings,","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.3233\/NRE-210071_ref13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1067\/mpd.2000.108393","article-title":"An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy","volume":"137","author":"Fehlings,","year":"2000","journal-title":"Journal of Pediatrics"},{"issue":"10","key":"10.3233\/NRE-210071_ref14","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.ridd.2014.06.001","article-title":"A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia","volume":"35","author":"Ferrari,","year":"2014","journal-title":"Research in Developmental Disabilities"},{"issue":"4","key":"10.3233\/NRE-210071_ref15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.hcl.2018.06.004","article-title":"Considerations in the management of upper extremity spasticity","volume":"34","author":"Gart,","year":"2018","journal-title":"Hand Clinics"},{"issue":"15","key":"10.3233\/NRE-210071_ref17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/09638280500404305","article-title":"A systematic review of the Tardieu Scale for the measurement of spasticity","volume":"28","author":"Haugh,","year":"2006","journal-title":"Disability and Rehabilitation"},{"issue":"5","key":"10.3233\/NRE-210071_ref18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/dmcn.12950","article-title":"Muscle growth is reduced in -month-old children with cerebral palsy","volume":"58","author":"Herskind,","year":"2016","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"8","key":"10.3233\/NRE-210071_ref19","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1185\/03007995.2010.497103","article-title":"Botulinum toxin type A in post-stroke upper limb spasticity","volume":"26","author":"Kaji,","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.3233\/NRE-210071_ref20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01241398-199307000-00013","article-title":"Management of cerebral palsy with botulinum-A toxin: preliminary investigation","volume":"13","author":"Koman,","year":"1993","journal-title":"Journal of Pediatric Orthopedics"},{"issue":"1","key":"10.3233\/NRE-210071_ref21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0883073816671681","article-title":"Hypertonia assessment tool: reliability and validity in children with neuromotor disorders","volume":"32","author":"Marsico,","year":"2017","journal-title":"Journal of Child Neurology"},{"issue":"2","key":"10.3233\/NRE-210071_ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11910-020-1022-z","article-title":"State of the evidence traffic lights: systematic review of interventions for preventing and treating children with cerebral palsy. Article","volume":"20","author":"Novak,","year":"2020","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"1","key":"10.3233\/NRE-210071_ref23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1469-8749.2009.03387.x","article-title":"Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: a randomized controlled trial","volume":"52","author":"Olesch,","year":"2010","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"10","key":"10.3233\/NRE-210071_ref24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/ptj\/73.10.651","article-title":"Validity of goal attainment scaling in infants with motor delays","volume":"73","author":"Palisano,","year":"1993","journal-title":"Phys Ther"},{"issue":"3","key":"10.3233\/NRE-210071_ref25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1651-2227.2009.01626.x","article-title":"Pain in children with cerebral palsy: a cross-sectional multicentre European study","volume":"99","author":"Parkinson,","year":"2010","journal-title":"Acta Paediatrica"},{"issue":"3","key":"10.3233\/NRE-210071_ref26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1469-8749.2010.03844.x","article-title":"Distribution of motor types in cerebral palsy: how do registry data compare?","volume":"53","author":"Reid,","year":"2011","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.3233\/NRE-210071_ref27","first-page":"8","article-title":"A report: the definition and classification of cerebral palsy April 2006","volume":"109","author":"Rosenbaum,","year":"2007","journal-title":"Developmental Medicine and Child Neurology. Supplement"},{"issue":"1","key":"10.3233\/NRE-210071_ref28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/dmcn.12865","article-title":"Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003","volume":"58","author":"Sellier,","year":"2016","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"4","key":"10.3233\/NRE-210071_ref29","first-page":"345","article-title":"Management of spasticity in children with cerebral palsy [Review]","volume":"24","author":"Shamsoddini,","year":"2014","journal-title":"Iranian Journal of Pediatrics"},{"issue":"8","key":"10.3233\/NRE-210071_ref31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/dmcn.13452","article-title":"A systematic review of scales to measure dystonia and choreoathetosis in children with dyskinetic cerebral palsy","volume":"59","author":"Stewart,","year":"2017","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"4","key":"10.3233\/NRE-210071_ref32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0749-0712(03)00044-1","article-title":"Casting, splinting, and physical and occupational therapy of hand deformity and dysfunction in cerebral palsy","volume":"19","author":"Wilton,","year":"2003","journal-title":"Hand Clinics"}],"container-title":["NeuroRehabilitation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/NRE-210071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:06:12Z","timestamp":1777615572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/NRE-210071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":27,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/nre-210071","relation":{},"ISSN":["1053-8135","1878-6448"],"issn-type":[{"value":"1053-8135","type":"print"},{"value":"1878-6448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]}}}